Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) have received an average recommendation of "Moderate Buy" from the ten ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have given a hold recommendation, one has given a buy recommendation and three have assigned a strong buy recommendation to the company.

Get RBGLY alerts:

A number of equities research analysts recently commented on the stock. JPMorgan Chase & Co. cut shares of Reckitt Benckiser Group from an "overweight" rating to a "neutral" rating in a research note on Thursday, August 29th. Citigroup upgraded shares of Reckitt Benckiser Group to a "strong-buy" rating in a research report on Tuesday, October 1st. Barclays upgraded Reckitt Benckiser Group to a "strong-buy" rating in a research report on Friday, October 4th. Finally, UBS Group upgraded Reckitt Benckiser Group to a "strong-buy" rating in a report on Wednesday, September 18th.

Check Out Our Latest Analysis on Reckitt Benckiser Group

Reckitt Benckiser Group Stock Up 0.4 %

RBGLY stock traded up $0.05 during trading on Friday, reaching $12.55. 160,289 shares of the company were exchanged, compared to its average volume of 820,093. Reckitt Benckiser Group has a 52-week low of $10.24 and a 52-week high of $15.03. The company has a quick ratio of 0.47, a current ratio of 0.69 and a debt-to-equity ratio of 0.97. The stock's 50 day moving average price is $11.87 and its 200 day moving average price is $11.38.

Ad Banyan Hill Publishing

Election rigged? We caught them red-handed…

What happens if NOBODY will be elected the next President of the United States on Nov. 5? Not Donald Trump. And not Kamala Harris. The end result could be a 50% drop in the stock market. You need to be ready.

Go here now for a FREE video about this surprising election forecast.

Reckitt Benckiser Group Cuts Dividend

The company also recently announced a dividend, which was paid on Monday, September 23rd. Investors of record on Monday, August 5th were given a $0.1915 dividend. The ex-dividend date of this dividend was Monday, August 5th.

About Reckitt Benckiser Group

(Get Free Report

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.

Should you invest $1,000 in Reckitt Benckiser Group right now?

Before you consider Reckitt Benckiser Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.

While Reckitt Benckiser Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report